Back to Featured Industry EventsRedefining Possibilities in HER2-Expressing mBC Care
Redefining Possibilities in HER2-Expressing mBC Care
December 10 @ 2:30 pm – 3:30 pm CST
Program Description
A program focused on broadening choices in the management of HER2-expressing mBC, presented by Daiichi Sankyo, Inc. and AstraZeneca
These are not an official program of the San Antonio Breast Cancer Symposium®.
Speakers
Presenter: Martin F Dietrich MD, PhD
Medical Oncologist
Orlando, FL